Mode
Text Size
Log in / Sign up
N/A N=604

Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes

Diabetic Foot · Peripheral Arterial Disease · Diabetic Foot Ulcer · Peripheral Vascular Diseases · Peripheral Artery Disease

Enrolled (actual)
604
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Diagnostic Accuracy — 36; 42; 55; 41 percentage

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Toe Brachial Pressure Index (TBPI) (Diagnostic_test); Ankle Brachial Pressure Index (ABPI) (Diagnostic_test); Exercise Ankle Brachial Pressure Index (ABPI) (Diagnostic_test); Audible handheld Doppler (Diagnostic_test); Visual handheld Doppler (Diagnostic_test); Podiatry Ankle Duplex scan (PAD-scan) (Diagnostic_test)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Imperial College London
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Diagnostic Accuracy
36; 42; 55; 41; 41; 89
PRIMARY
Diagnostic Accuracy - Ratios
0.7; 0.7; 0.6; 0.7; 0.7; 0.2
SECONDARY
Health Economic Outcome - Cost Effectiveness
11165437; 11204467; 11241003; 11218496; 11229209; 11156745
SECONDARY
Health Economic Outcome - Cost Effectiveness (QALY)
2418; 2426; 2442; 2425; 2425; 2370
SECONDARY
Patient Acceptability
7; 7; 7; 11; 8; 2
SECONDARY
Technical Success
603; 603; 590; 599; 540; 102

Summary

In the UK there are over 7,000 leg amputations each year because of diabetes. The most important cause of this is poor circulation. The detection of poor circulation in patients with diabetes is difficult. A number of tests exist to detect poor circulation (known as peripheral arterial disease (PAD)). However, there is confusion as to which is the gold standard. The DM PAD study aims to determine the diagnostic performance of index tests (audible handheld Doppler, visual handheld Doppler, ankle brachial pressure index (ABPI), exercise ABPI and toe brachial pressure index (TBPI)) for the diagnosis of PAD in patients with diabetes as determined by a reference test (CTA or MRA).

Eligibility Criteria

Inclusion Criteria

  • Aged ≥18 years
  • Known history of diabetes

Exclusion Criteria

  • PAD status known on imaging
  • Known history of PAD intervention
  • CTA and MRA contraindications- renal impairment, pregnancy, contrast medium hypersensitivity/allergy, non-compatible implants (MRA only).
  • Unable to provide appropriate informed consent.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05009602). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search